Assessment of Glioblastoma Response in the Era of Bevacizumab: Longstanding and Emergent Challenges in the Imaging Evaluation of Pseudoresponse

Glioblastoma is the deadliest primary malignant brain neoplasm, and despite the availability of many treatment options, its prognosis remains somber. Enhancement detected by magnetic resonance imaging (MRI) was considered the best imaging marker of tumor activity in glioblastoma for decades. However...

Descripción completa

Detalles Bibliográficos
Autores principales: Arevalo, Octavio D., Soto, Carolina, Rabiei, Pejman, Kamali, Arash, Ballester, Leomar Y., Esquenazi, Yoshua, Zhu, Jay-Jiguang, Riascos, Roy Francisco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6514158/
https://www.ncbi.nlm.nih.gov/pubmed/31133966
http://dx.doi.org/10.3389/fneur.2019.00460

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6514158/
https://www.ncbi.nlm.nih.gov/pubmed/31133966
http://dx.doi.org/10.3389/fneur.2019.00460

Ejemplares similares